These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10036720)

  • 1. An experimental vaccine that targets staphylococcal virulence.
    Lee JC
    Trends Microbiol; 1998 Dec; 6(12):461-3. PubMed ID: 10036720
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and immunotherapy of staphylococcal infections with bacterial vaccines].
    Kuz'menko OM; Gruber IM; Priiatkin RG
    Zh Mikrobiol Epidemiol Immunobiol; 2010; (5):106-12. PubMed ID: 21061586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new view on development of a Staphylococcus aureus vaccine: insights from mice and men.
    Spellberg B; Daum R
    Hum Vaccin; 2010 Oct; 6(10):857-9. PubMed ID: 20930569
    [No Abstract]   [Full Text] [Related]  

  • 4. Which are important targets in development of S. aureus mastitis vaccine?
    Scali F; Camussone C; Calvinho LF; Cipolla M; Zecconi A
    Res Vet Sci; 2015 Jun; 100():88-99. PubMed ID: 25975626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of vaccine against Staphylococcus aureus recovered from naturally occurring mastitis in she-camels.
    Aqib AI; Anjum AA; Ijaz M; Hussain R; Ahmed R; Farooqi SH; Aslam HB; Hussain K; Mehmood K; Zhang H
    Microb Pathog; 2018 Apr; 117():341-347. PubMed ID: 29510207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a conjugate polysaccharide vaccine in the prevention of invasive staphylococcal disease: is an additional vaccine needed or possible?
    Shinefield HR
    Vaccine; 2006 Apr; 24 Suppl 2():S2-65-9. PubMed ID: 16823932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C
    Med Sci Monit; 2002 Sep; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract]   [Full Text] [Related]  

  • 10. The prospects for developing a vaccine against Staphylococcus aureus.
    Lee JC
    Trends Microbiol; 1996 Apr; 4(4):162-6. PubMed ID: 8728611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.
    Bagnoli F; Bertholet S; Grandi G
    Front Cell Infect Microbiol; 2012; 2():16. PubMed ID: 22919608
    [No Abstract]   [Full Text] [Related]  

  • 12. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR
    Expert Rev Vaccines; 2008 Aug; 7(6):805-15. PubMed ID: 18665778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLP-based vaccine induces immune control of Staphylococcus aureus virulence regulation.
    Daly SM; Joyner JA; Triplett KD; Elmore BO; Pokhrel S; Frietze KM; Peabody DS; Chackerian B; Hall PR
    Sci Rep; 2017 Apr; 7(1):637. PubMed ID: 28377579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for a MRSA vaccine.
    Lindsay JA
    Future Microbiol; 2007 Feb; 2(1):1-3. PubMed ID: 17661669
    [No Abstract]   [Full Text] [Related]  

  • 15. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA
    Vaccine; 2012 Apr; 30(19):2921-7. PubMed ID: 22115633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models matter: the search for an effective Staphylococcus aureus vaccine.
    Salgado-Pabón W; Schlievert PM
    Nat Rev Microbiol; 2014 Aug; 12(8):585-91. PubMed ID: 24998740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity.
    Nilsson IM; Verdrengh M; Ulrich RG; Bavari S; Tarkowski A
    J Infect Dis; 1999 Oct; 180(4):1370-3. PubMed ID: 10479175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine review: "Staphyloccocus aureus vaccines: problems and prospects".
    Jansen KU; Girgenti DQ; Scully IL; Anderson AS
    Vaccine; 2013 Jun; 31(25):2723-30. PubMed ID: 23624095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staphylococcus aureus vaccine against mastitis in dairy cows, composition and evaluation of its immunogenicity in a mouse model.
    Leitner G; Lubashevsky E; Trainin Z
    Vet Immunol Immunopathol; 2003 Jun; 93(3-4):159-67. PubMed ID: 12814701
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wójcik-Bojek U; Różalska B; Sadowska B
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.